Sperax is projected to rise to $0.004112 by 2027, a +46% move from its current price of $0.002825. SPA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 22/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 5/26/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.002722 | $0.002827 | $0.002936 | +0.06% |
| May 30 | $0.002682 | $0.002829 | $0.002984 | +0.12% |
| May 31 | $0.002651 | $0.00283 | $0.003021 | +0.17% |
| Jun 1 | $0.002626 | $0.002832 | $0.003054 | +0.23% |
| Jun 2 | $0.002604 | $0.002834 | $0.003083 | +0.29% |
| Jun 3 | $0.002585 | $0.002835 | $0.00311 | +0.35% |
| Jun 4 | $0.002567 | $0.002837 | $0.003134 | +0.40% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.002567 | $0.002837 | $0.003134 | +0.40% |
| Week 2 | $0.002473 | $0.002848 | $0.00328 | +0.81% |
| Week 3 | $0.002406 | $0.00286 | $0.003399 | +1.22% |
| Week 4 | $0.002352 | $0.002871 | $0.003505 | +1.62% |
| Week 5 | $0.002306 | $0.002883 | $0.003603 | +2.04% |
| Week 6 | $0.002267 | $0.002895 | $0.003696 | +2.45% |
| Week 7 | $0.002232 | $0.002906 | $0.003784 | +2.86% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sperax is redefining financial autonomy through programmable agents that manage capital, optimize yield, and protect against risk, all transparently on-chain. Founded in 2019, Sperax is backed by Jump Trading, Polychain Capital, Amber Group. The SperaxOS ecosystem is powered by USDs and SPA on Arbitrum, BNB Chain, and other EVM networks.
Anchored by two native assets: USDs, a gas-free, auto-yield stablecoin backed by on-chain collateral, and SPA, the governance and value-capture token. Sperax builds open-source tools that turn idle capital into self-optimizing portfolios, with Demeter, a no-code platform for launching liquidity farms.
Sperax SPA trades at $0.002825 and has a market cap of $5.41M, ranking 1617. The asset’s all-time high is $0.2395 and all-time low is $0.002603, providing context for its price range. The year-by-year forecast points to a mixed near-term path with potential upside in select years, including a 2027 average near $0.004112 and a 2030 average of $0.004454, with a 2030 max of $0.007008.
The forecast also shows later-year bullish opportunities, with a 2050 average of $0.007844 and a max of $0.0166, underscoring a long-run growth runway amidst volatility.
A major floor 21.7% below — a decisive break under it would weaken the trend.
The nearest floor, 6.5% below — buyers have tended to step in here.
The nearest ceiling, 19.6% above — a clean break opens room to run.
A major ceiling 30.5% above — clearing it would confirm fresh momentum.
Key SPA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SPA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.002877 | Sell | $0.002874 | Sell |
| MA 10 | $0.002916 | Sell | $0.002905 | Sell |
| MA 20 | $0.002949 | Sell | $0.002919 | Sell |
| MA 50 | $0.002944 | Sell | $0.002988 | Sell |
| MA 100 | $0.003172 | Sell | $0.003319 | Sell |
| MA 200 | $0.003981 | Sell | $0.004606 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.36 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -70.88 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -5.91 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.04 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 39.39 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 0.00 | Sell |
| ADX (14) | 11.41 | Neutral |
| ATR (14) | 0.00 | Info |
Technically, the 30-day picture is bearish overall, with RSI14 at 50 and near-term momentum subdued. The moving averages show SMA50 at $0.002944 and SMA200 at $0.003981, suggesting resistance above the current price. Key levels to watch are support at $0.002642 and resistance at $0.00338, with the 30-day price range spanning $0.002298 to $0.003474.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.002642 | $0.002825 | $0.005372 | 0% | Neutral | |
| $0.003139 | $0.004112 | $0.005773 | +46% | Bullish | |
| $0.001475 | $0.00201 | $0.002956 | -29% | Bearish | |
| $0.001946 | $0.002742 | $0.004183 | -3% | Neutral | |
| $0.00307 | $0.004454 | $0.007008 | +58% | Bullish | |
| $0.002483 | $0.003704 | $0.005986 | +31% | Bullish | |
| $0.002164 | $0.003312 | $0.005482 | +17% | Neutral | |
| $0.001872 | $0.002937 | $0.004967 | +4% | Neutral | |
| $0.003254 | $0.005225 | $0.009014 | +85% | Bullish | |
| $0.002941 | $0.004831 | $0.008488 | +71% | Bullish | |
| $0.002141 | $0.003909 | $0.007412 | +38% | Bullish | |
| $0.003544 | $0.007844 | $0.0166 | +178% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.002642 | $0.002825 | $0.003464 | +0.00% |
| June 2026 | $0.002529 | $0.002998 | $0.003658 | +6.10% |
| July 2026 | $0.002483 | $0.002978 | $0.0037 | -0.67% |
| August 2026 | $0.002874 | $0.003478 | $0.004381 | +16.80% |
| September 2026 | $0.003023 | $0.003686 | $0.004696 | +5.98% |
| October 2026 | $0.002754 | $0.003381 | $0.004352 | -8.27% |
| November 2026 | $0.002861 | $0.003535 | $0.00459 | +4.53% |
| December 2026 | $0.003301 | $0.004102 | $0.005372 | +16.06% |
Click any year to see its month-by-month SPA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Sperax's 2026 outlook centres on $0.002825, within a $0.002642 to $0.005372 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, SPA could reach as high as $0.005773, with a base case around $0.004112 and support toward $0.003139 — roughly +46% from $0.002825. Momentum favours further upside here.
Expect SPA to range from $0.001475 to $0.002956 through 2028. The $0.00201 average target implies a -29% move from current prices. That is -51% versus the projected 2027 average. Expect choppier, lower action through this leg of the cycle.
The SPA price prediction for 2029 points to an average of $0.002742 (low $0.001946, high $0.004183) — a potential decline of -3% on today's $0.002825. Price action looks broadly range-bound.
In 2030, SPA is projected to trade between $0.00307 and $0.007008, averaging $0.004454 — a potential gain of +58% from today's $0.002825. That is up +62% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Sperax's 2031 outlook centres on $0.003704, within a $0.002483 to $0.005986 range. That is -17% versus the projected 2030 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2032, SPA could reach as high as $0.005482, with a base case around $0.003312 and support toward $0.002164 — roughly +17% from $0.002825. A consolidation phase looks the most probable path here.
Expect SPA to range from $0.001872 to $0.004967 through 2033. The $0.002937 average target implies a +4% move from current prices. That is -11% versus the projected 2032 average. Price action looks broadly range-bound.
The SPA price prediction for 2034 points to an average of $0.005225 (low $0.003254, high $0.009014) — a potential gain of +85% on today's $0.002825. Buyers look set to stay in control over this stretch.
In 2035, SPA is projected to trade between $0.002941 and $0.008488, averaging $0.004831 — a potential gain of +71% from today's $0.002825. That is -8% versus the projected 2034 average. Momentum favours further upside here.
Sperax's 2040 outlook centres on $0.003909, within a $0.002141 to $0.007412 range. That is -19% versus the projected 2035 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, SPA could reach as high as $0.0166, with a base case around $0.007844 and support toward $0.003544 — roughly +178% from $0.002825. Momentum favours further upside here.
Investing $1,000 in SPA today (≈ 353,932.186593 SPA) could be worth
$2,776.29
+$1,776.29 (+178%) by 2050 · US Dollar
Based on the average projected SPA price of $0.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SPAwould be worth at today's price.
$1,000 invested in SPA on May 26, 2025 (≈ 56,757.889469 SPA) would be worth
$160.36
-$839.64 (-84.0%) today · 0.16× · US Dollar
Based on a SPA entry price of $0.017619 vs. today's $0.002825.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.002881 | $980.59 | -1.9% |
| 1 month ago | $0.002764 | $1,022.34 | +2.2% |
| 3 months ago | $0.003275 | $862.84 | -13.7% |
| 6 months ago | $0.006071 | $465.38 | -53.5% |
| 1 year ago | $0.017619 | $160.36 | -84.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SPA forecast.
Our base-case forecast reaches $0.0057 around 2050.
Implied market cap at $0.0057: $10.9M
The multi-year forecast highlights a bullish tilt by 2030, with an average price of $0.004454 and a max of $0.007008, representing a 57.6% ROI in that year. In 2040, the average is projected at $0.003909 with a 38.3% ROI and a bullish outlook, while 2050 shows a stronger long-run profile with an average of $0.007844 and a 177.6% ROI. Earlier years exhibit more variability, with 2026 averaging $0.002825 (ROI 0%) and 2027 averaging $0.004112 (ROI 45.5%), while 2028 can see a negative return of -28.9% (avg $0.00201).
These numbers illustrate a path to higher long-run values, but also emphasize notable year-to-year volatility and risk, consistent with a non-stable, crypto-asset profile.
Tap a question to reveal the answer.
The forecasted average price in 2030 is $0.004454, with a min of $0.00307 and a max of $0.007008, and a forecasted ROI of 57.6%. The sentiment for 2030 is BULLISH.
Forecasts show a mix of outcomes: 2027 average $0.004112 with ROI 45.5% (BULLISH), and 2028 average $0.00201 with ROI -28.9% (BEARISH). The 2030 average is $0.004454 with ROI 57.6% (BULLISH). These are estimates, not guarantees, and reflect potential upsides and risks.
The year-by-year max prices include $0.007008 in 2030, $0.009014 in 2034, and $0.0166 in 2050. Since $0.01 lies above the 2030 and 2034 maxes but below the 2050 max, the forecast suggests $0.01 could be surpassed by 2050 in the model’s high-end scenario.
The current price is $0.002825 and the market cap is $5.41M.
Annualized volatility is 70%.
Sperax Community Discussion
0Share your Sperax price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.